This review aims to enhance the molecular understanding of CLL by exploring the critical role of BCR signalling and its associated pathways, such as NF-κB, PI3K/AKT, and ROR1, in sustaining CLL cell survival, proliferation, and resistance to apoptosis. This evidence concerns the gene AKT1 and B-cell chronic lymphocytic leukemia.